Evidence map›Paper›PMID 40371023›Full record

ArticleIndian journal of microbiology2025

Advancing Frontiers: Graphene-Based Nano-biosensor Platforms for Cutting-Edge Research and Future Innovations.

Niket Rana, Jasjeet Narang, Arjun Chauhan

Abstract read
In one paragraph

Article in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Niket RanaDepartment of Biotechnology, Panjab University, Sector 25, Chandigarh, 160014 India.
Jasjeet NarangUniversity Institute of Biotechnology, Chandigarh University, Punjab, 140413 India.
Arjun ChauhanDepartment of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, Uttar Pradesh 281406 India.ORCID 0000-0003-1188-8386

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene and its derivatives have excellent electrical, mechanical, and optical capabilities, making it the perfect foundation for sensing living things. Graphene-based nano biosensors have shown exceptional sensitivity, selectivity, and quick response times when used to detect a range of analytes, such as biomolecules, cells, and pathogens. The main uses of graphene-based nano biosensors are disease diagnosis, environmental monitoring, food safety, and drug development. It also explores prospective future strategies, such as methods for functionalizing nanomaterials, their incorporation with other nanomaterials, and the creation of wearable and implantable gadgets. Various signalling techniques, such as fluorescence, electrochemistry, surface plasmon resonance, surface-enhanced Raman scattering, etc., can be coupled with graphene-based biosensors to quantitatively detect disease-associated DNA, RNA, and protein biomarkers quantitatively. Graphene-based nano biosensors, combined with cutting-edge innovations like artificial intelligence and the Internet of Things, can completely transform industries like healthcare and environmental monitoring. Developing these biosensors with high sensitivity and low detection limits provides a new direction in medical and personal care. The later portion of the review covers the difficulties, prospective fixes, and opportunities of graphene-based biosensors.

Indexed as

ApplicationDetectionDNAGrapheneGraphene oxideNano-biosensorsPathogens

Identifiers

PMID40371023
PMCPMC12069184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.